GenFleet Therapeutics

📍 Shanghai, China👥 28 employees💰 Last funded Jun 2024
Pharmaceutical Manufacturing🌐 genfleet.com
Website LinkedIn
Dedicated to serving significant unmet medical needs, GenFleet Therapeutics constructs its R&D platform on the basis of disease biology and translational medicine, and researches into latest biological mechanism of cancer pathways, tumor microenvironment and human immunoregulation. GenFleets rich and diversified pipeline highlights multiple cutting-edge products with novel mechanisms and global intellectual property rights. Through years of endeavor, GenFleet has set up industry-leading capabilities and expertise in developing novel drugs - both small molecules and biologics. Its cutting-edge pipeline includes over 10 products, three of which have progressed into clinical stages. As more projects move into late-stage clinical trials, GenFleet is expected to unravel its blueprint of commercialization during the next 3-5 years.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
1
Frequently asked questions
Who invested in GenFleet Therapeutics?
GenFleet Therapeutics has 1 investors on record on gritt.io.
When did GenFleet Therapeutics last raise funding?
The most recent investment in GenFleet Therapeutics recorded on gritt.io was in June 2024.
What industry is GenFleet Therapeutics in?
GenFleet Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is GenFleet Therapeutics based?
GenFleet Therapeutics is headquartered in Shanghai, China.